OR WAIT null SECS
© 2022 MJH Life Sciences™ and Contemporary Pediatrics. All rights reserved.
Abbott's Humira (adalimumab) had been approved by the food and Drug Administration for its sixth indication, juvenile rheumatoid arthritis...
Abbott's Humira (adalimumab) has been approved by the Food and Drug Administration for its sixth indication, juvenile rheumatoid arthritis.
JVA joins other indications including chronic plaque psoriasis, rheumatoid arthritis in adults, and Crohn's disease.